Enebo, L., Berthelsen, K., Kankam, M., Lund, M., Rubino, D., Satylganova, A., & Lau, D
13 In its phase III clinical study, Donanemab reduced amyloid plaque on average by 84% at 18 months, compared to a 1% decrease for patients on placebo
Joint pain and stiffness Growth hormone promotes tissue repair and growth
BPC-157 (Body Protection Compound-157), also designated as PL 14736, is a synthetic pentadecapeptide composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) that was first isolated and identified from human gastric juice in the early 1990s
I., Aboud, O
PVD is often caused by diabetes or hardening of the arteries (atherosclerosis)